Sincalide Injection, Powder, Lyophilized, For Solution
Product Images NDC 70511-131

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sincalide (NDC 70511-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Maia Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sincalide Structure (Sincalide Structure)

Chemical structure of sincalide showing its peptide sequence of eight amino acids: Asp, Tyr (with a sulfonic acid group), Met, Gly, Trp, Met, Asp, and Phe. Molecular formula C49H62N10O16S3 with molecular weight 1143.27 and CAS number 25126-32-3 is displayed.*

FDA Label Image

Vial Label (Vial)

Label for Sincalide injection, powder, lyophilized, for solution, 5 mcg per vial. It is intended for intravenous use and supplied as a single-dose vial. The label includes storage instructions and manufacturing details by MAIA Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.